Despite solid company performance and promising revenue outl...
Despite solid company performance and promising revenue outlook, P/S ratio isn't fully impacted, possibly due to investors' doubt on meeting growth expectations. If analysts' predictions are right, it could be a buying opportunity.
The Market Lifts The Oncology Institute, Inc. (NASDAQ:TOI) Shares 49% But It Can Do More
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment